216 related articles for article (PubMed ID: 33619989)
1. Triazole-containing hybrids with anti-
Tan Z; Deng J; Ye Q; Zhang Z
Future Med Chem; 2021 Apr; 13(7):643-662. PubMed ID: 33619989
[TBL] [Abstract][Full Text] [Related]
2. Advances in the application of 1,2,4-triazole-containing hybrids as anti-tuberculosis agents.
Cao Y; Lu H
Future Med Chem; 2021 Dec; 13(23):2107-2124. PubMed ID: 34698509
[TBL] [Abstract][Full Text] [Related]
3. Triazole derivatives and their anti-tubercular activity.
Zhang S; Xu Z; Gao C; Ren QC; Chang L; Lv ZS; Feng LS
Eur J Med Chem; 2017 Sep; 138():501-513. PubMed ID: 28692915
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
Gao F; Chen Z; Ma L; Fan Y; Chen L; Lu G
Eur J Med Chem; 2019 Oct; 180():648-655. PubMed ID: 31352245
[TBL] [Abstract][Full Text] [Related]
5. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives.
Costa MS; Boechat N; Rangel EA; da Silva Fde C; de Souza AM; Rodrigues CR; Castro HC; Junior IN; Lourenço MC; Wardell SM; Ferreira VF
Bioorg Med Chem; 2006 Dec; 14(24):8644-53. PubMed ID: 16949290
[TBL] [Abstract][Full Text] [Related]
7. Emerging impact of triazoles as anti-tubercular agent.
Sharma A; Agrahari AK; Rajkhowa S; Tiwari VK
Eur J Med Chem; 2022 Aug; 238():114454. PubMed ID: 35597009
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis.
Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2014 Apr; 24(8):1974-9. PubMed ID: 24679703
[TBL] [Abstract][Full Text] [Related]
9. Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis.
Yempala T; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
Eur J Med Chem; 2014 Jan; 71():160-7. PubMed ID: 24292337
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 1,2,4-triazole-3-thione and 1,3,4-oxadiazole-2-thione as antimycobacterial agents.
Sonawane AD; Rode ND; Nawale L; Joshi RR; Joshi RA; Likhite AP; Sarkar D
Chem Biol Drug Des; 2017 Aug; 90(2):200-209. PubMed ID: 28083914
[TBL] [Abstract][Full Text] [Related]
11. A convenient synthesis and screening of benzosuberone bearing 1,2,3-triazoles against Mycobacterium tuberculosis.
Sajja Y; Vanguru S; Jilla L; Vulupala HR; Bantu R; Yogeswari P; Sriram D; Nagarapu L
Bioorg Med Chem Lett; 2016 Sep; 26(17):4292-5. PubMed ID: 27476139
[TBL] [Abstract][Full Text] [Related]
12. 1H-1,2,3-Triazole tethered isatin-moxifloxacin: Design, synthesis and in vitro anti-mycobacterial evaluation.
Jiang Y; Qian A; Li Y
Arch Pharm (Weinheim); 2019 Jul; 352(7):e1900040. PubMed ID: 31106443
[TBL] [Abstract][Full Text] [Related]
13. Clubbed triazoles: a novel approach to antitubercular drugs.
Shiradkar M; Suresh Kumar GV; Dasari V; Tatikonda S; Akula KC; Shah R
Eur J Med Chem; 2007 Jun; 42(6):807-16. PubMed ID: 17239490
[TBL] [Abstract][Full Text] [Related]
14. One-pot synthesis of new triazole--Imidazo[2,1-b][1,3,4]thiadiazole hybrids via click chemistry and evaluation of their antitubercular activity.
Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2015 Oct; 25(19):4169-73. PubMed ID: 26298500
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
Phatak PS; Bakale RD; Kulkarni RS; Dhumal ST; Dixit PP; Krishna VS; Sriram D; Khedkar VM; Haval KP
Bioorg Med Chem Lett; 2020 Nov; 30(22):127579. PubMed ID: 32987135
[TBL] [Abstract][Full Text] [Related]
16. Gatifloxacin-1,2,3-triazole-isatin hybrids and their antimycobacterial activities.
Ding Z; Hou P; Liu B
Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900135. PubMed ID: 31441087
[TBL] [Abstract][Full Text] [Related]
17. Click chemistry approach for bis-chromenyl triazole hybrids and their antitubercular activity.
Naik RJ; Kulkarni MV; Sreedhara Ranganath Pai K; Nayak PG
Chem Biol Drug Des; 2012 Oct; 80(4):516-23. PubMed ID: 22737986
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and molecular docking study of novel triazole-quinazolinone hybrids as antimalarial and antitubercular agents.
Mhetre UV; Haval NB; Bondle GM; Rathod SS; Choudhari PB; Kumari J; Sriram D; Haval KP
Bioorg Med Chem Lett; 2024 Aug; 108():129800. PubMed ID: 38763480
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and in vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids.
Xu Z; Zhang S; Song X; Qiang M; Lv Z
Bioorg Med Chem Lett; 2017 Aug; 27(16):3643-3646. PubMed ID: 28720502
[TBL] [Abstract][Full Text] [Related]
20. Ciprofloxacin-1,2,3-triazole-isatin hybrids tethered via amide: Design, synthesis, and in vitro anti-mycobacterial activity evaluation.
Chen R; Zhang H; Ma T; Xue H; Miao Z; Chen L; Shi X
Bioorg Med Chem Lett; 2019 Sep; 29(18):2635-2637. PubMed ID: 31358466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
